313 related articles for article (PubMed ID: 34011606)
1. DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditions.
Sato K; Yamashita-Kanemaru Y; Abe F; Murata R; Nakamura-Shinya Y; Kanemaru K; Muratani M; Veillette A; Goto M; Ito M; Shibuya A; Shibuya K
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34011606
[TBL] [Abstract][Full Text] [Related]
2. DNAM-1 versus TIGIT: competitive roles in tumor immunity and inflammatory responses.
Shibuya A; Shibuya K
Int Immunol; 2021 Nov; 33(12):687-692. PubMed ID: 34694361
[TBL] [Abstract][Full Text] [Related]
3. Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226.
Fuhrman CA; Yeh WI; Seay HR; Saikumar Lakshmi P; Chopra G; Zhang L; Perry DJ; McClymont SA; Yadav M; Lopez MC; Baker HV; Zhang Y; Li Y; Whitley M; von Schack D; Atkinson MA; Bluestone JA; Brusko TM
J Immunol; 2015 Jul; 195(1):145-55. PubMed ID: 25994968
[TBL] [Abstract][Full Text] [Related]
4. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
[TBL] [Abstract][Full Text] [Related]
5. Characteristic of TIGIT and DNAM-1 Expression on Foxp3+
Jin Z; Ye W; Lan T; Zhao Y; Liu X; Chen J; Lai J; Chen S; Zhong X; Wu X
Biomed Res Int; 2020; 2020():4612952. PubMed ID: 32802845
[TBL] [Abstract][Full Text] [Related]
6. The TIGIT/CD226 axis regulates human T cell function.
Lozano E; Dominguez-Villar M; Kuchroo V; Hafler DA
J Immunol; 2012 Apr; 188(8):3869-75. PubMed ID: 22427644
[TBL] [Abstract][Full Text] [Related]
7. Promoting regulation via the inhibition of DNAM-1 after transplantation.
Koyama M; Kuns RD; Olver SD; Lineburg KE; Lor M; Teal BE; Raffelt NC; Leveque L; Chan CJ; Robb RJ; Markey KA; Alexander KA; Varelias A; Clouston AD; Smyth MJ; MacDonald KP; Hill GR
Blood; 2013 Apr; 121(17):3511-20. PubMed ID: 23430112
[TBL] [Abstract][Full Text] [Related]
8. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
[TBL] [Abstract][Full Text] [Related]
9. Helios but not CD226, TIGIT and Foxp3 is a Potential Marker for CD4
Yang M; Liu Y; Mo B; Xue Y; Ye C; Jiang Y; Bi X; Liu M; Wu Y; Wang J; Olsen N; Pan Y; Zheng SG
Cell Physiol Biochem; 2019; 52(5):1178-1192. PubMed ID: 30990587
[TBL] [Abstract][Full Text] [Related]
10. Essential role of CD155 glycosylation in functional binding to DNAM-1 on natural killer cells.
Tahara S; Okumura G; Matsuo T; Shibuya A; Shibuya K
Int Immunol; 2024 Apr; 36(6):317-325. PubMed ID: 38289706
[TBL] [Abstract][Full Text] [Related]
11. TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells.
Zhang D; Hu W; Xie J; Zhang Y; Zhou B; Liu X; Zhang Y; Su Y; Jin B; Guo S; Zhuang R
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3085-3098. PubMed ID: 29960041
[TBL] [Abstract][Full Text] [Related]
12. Foxp3 and Toll-like receptor signaling balance T
Gerriets VA; Kishton RJ; Johnson MO; Cohen S; Siska PJ; Nichols AG; Warmoes MO; de Cubas AA; MacIver NJ; Locasale JW; Turka LA; Wells AD; Rathmell JC
Nat Immunol; 2016 Dec; 17(12):1459-1466. PubMed ID: 27695003
[TBL] [Abstract][Full Text] [Related]
13. CD155 mutation (Ala67Thr) increases the binding affinity for and the signaling via an inhibitory immunoreceptor TIGIT.
Matsuo T; Iguchi-Manaka A; Shibuya A; Shibuya K
Cancer Sci; 2022 Nov; 113(11):4001-4004. PubMed ID: 35947095
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of TIGIT and FCRL3 identifies Helios+ human memory regulatory T cells.
Bin Dhuban K; d'Hennezel E; Nashi E; Bar-Or A; Rieder S; Shevach EM; Nagata S; Piccirillo CA
J Immunol; 2015 Apr; 194(8):3687-96. PubMed ID: 25762785
[TBL] [Abstract][Full Text] [Related]
15. Insulin-Like Growth Factors Are Key Regulators of T Helper 17 Regulatory T Cell Balance in Autoimmunity.
DiToro D; Harbour SN; Bando JK; Benavides G; Witte S; Laufer VA; Moseley C; Singer JR; Frey B; Turner H; Bruning J; Darley-Usmar V; Gao M; Conover C; Hatton RD; Frank S; Colonna M; Weaver CT
Immunity; 2020 Apr; 52(4):650-667.e10. PubMed ID: 32294406
[TBL] [Abstract][Full Text] [Related]
16. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
[TBL] [Abstract][Full Text] [Related]
17. Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.
Gilbert RM; Zhang X; Sampson RD; Ehrenstein MR; Nguyen DX; Chaudhry M; Mein C; Mahmud N; Galatowicz G; Tomkins-Netzer O; Calder VL; Lightman S
Front Immunol; 2018; 9():907. PubMed ID: 29774027
[TBL] [Abstract][Full Text] [Related]
18. Mouse Double Minute 2 Homolog-Mediated Ubiquitination Facilitates Forkhead Box P3 Stability and Positively Modulates Human Regulatory T Cell Function.
Wang A; Yang M; Liang R; Zhu F; Zhu F; Liu X; Han Y; Lin R; Wang X; Li D; Li H; Yuan X; Zhao H; Li B
Front Immunol; 2020; 11():1087. PubMed ID: 32636834
[TBL] [Abstract][Full Text] [Related]
19. Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease.
Du X; Shi H; Li J; Dong Y; Liang J; Ye J; Kong S; Zhang S; Zhong T; Yuan Z; Xu T; Zhuang Y; Zheng B; Geng JG; Tao W
J Immunol; 2014 Feb; 192(4):1525-35. PubMed ID: 24453252
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of canonical NF-κB signaling maintains function and stability of human Treg.
Ziegler LS; Gerner MC; Schmidt RLJ; Trapin D; Steinberger P; Pickl WF; Sillaber C; Egger G; Schwarzinger I; Schmetterer KG
FEBS J; 2021 Jan; 288(2):640-662. PubMed ID: 32386462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
